Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Where Will Vaxart Be in 1 Year?
2 Covid vaccine hopeful subleases space on Peninsula
3 Vaxart Reports More Positive Data From Animal Testing of Its Coronavirus Vaccine Candidate
4 VXRT Stock Price: Vaxart Inc set to extend winning streak with its dark horse coronavirus vaccine
5 Vaxart Reports Third Quarter 2020 Financial Results and Provides Business Update
6 Vaxart Announces Presentations at the Jefferies Virtual London Healthcare Conference & the Piper Sandler Annual Healthcare Conference
7 If You Invested $5,000 in Vaxart During the Last Recession, This Is How Much You Would Have Today
8 If You Invested $5,000 in Vaxart In January, This Is How Much You Would Have Today
9 Vaxart, Inc. (NASDAQ:VXRT) Director Wouter Latour Sells 333,334 Shares
10 If You Had Bought Vaxart (NASDAQ:VXRT) Stock A Year Ago, You Could Pocket A 910% Gain Today
11 What is the Market's View on Vaxart Inc (VXRT) Stock's Price and Volume Trends
12 3 Stocks with Jaw-Dropping Growth Potential
13 What Does The Future Hold For Vaxart, Inc. (NASDAQ:VXRT)? These Analysts Have Been Cutting Their Estimates
14 Vaxart (NASDAQ:VXRT) Stock Price Down 12.1% Following Insider Selling
15 Vaxart Has Developed the First Oral Investigational COVID-19 Vaccine
16 Vaxart (VXRT) to Report Q3 Earnings: What's in the Cards?
17 Why Inovio Pharmaceuticals, Novavax, and Vaxart Crashed in October
18 Vaxart Shareholder Drops Federal Derivative Suit Over Vaccine
19 Vaxart, Inc. (NASDAQ:VXRT) Stock: Performance and Outlook
20 It’s Time to Buy the lift in Vaxart Inc. [VXRT] Stock
21 Vaxart Inc. (VXRT) Just Got Our Attention | News Heater
22 H.C. Wainwright lifts Vaxart Inc. [VXRT] price estimate. Who else is bullish?
23 Can Vaxart Inc. (VXRT) Remain Competitive? | News Heater
24 Vaxart Inc. [VXRT] gain 1326.53% so far this year. What now?
25 Do Analysts Expect Vaxart Inc (VXRT) Stock to Rise?
26 $1.60 Million in Sales Expected for Vaxart, Inc. (NASDAQ:VXRT) This Quarter
27 3 Long-Shot Coronavirus Vaccine Stocks to Watch in December
28 Vaxart Inc. (NASDAQ:VXRT) on the Path to Profitability
29 The Trend in Vaxart, Inc. (NASDAQ:VXRT) Continues to Point Downwards
30 Is There a Dimmer Outlook Ahead for Vaxart Inc. (VXRT)? | News Heater
31 Pre-market Movers In Healthcare Sector: COCP, ADXS, VXRT, HEPA…
32 2 Under-the-Radar Coronavirus Vaccine Stocks to Watch
33 Avoid These 2 Coronavirus Innovator Stocks in November
34 Vaxart EPS beats by $0.01, misses on revenue
35 Analysts Pound the Table on This ‘Strong Buy’ Coronavirus Stock
36 How is the Vaxart, Inc. (NASDAQ:VXRT) performance outlook for the coming months?
37 These 2 Coronavirus Vaccine Stocks Could Be Game-Changers
38 Biotech Co. Investors Battle To Lead COVID-19 Vaccine Suit
39 Vaxart (VXRT) Gets a Buy Rating from H.C. Wainwright
40 Vaxart, Inc. (NASDAQ:VXRT) Short Interest Up 21.1% in October
41 Vaxart Inc. (VXRT) Open at price of $5.03: A Brand-New Opportunity for Investors
42 Vaxart Reports Q3 Rev Of $265,000 Versus $454,000
43 Vaxart Inc. [VXRT] Is Still Undervalued at $5.25
44 Vaxart Inc. (VXRT) is on the roll with an average volume of 17.86M in the recent 3 months
45 Vaxart, Inc. (NASDAQ:VXRT) Down Almost -22.34% in 1 Month, But Long Term Looking Good
46 Should Vaxart Inc (VXRT) be in Your Portfolio?
47 Vaxart Inc. (VXRT) is heading in the right direction with an average volume of $19.60M
48 Vaxart, Inc. (NASDAQ:VXRT) shares surges 5.35% in a week – but can it keep rising?
49 Disruptor Alert: These 2 Companies Are Changing Healthcare
50 Vaxart, Inc. (VXRT) Worth Considering For The Next Few Weeks
51 Analysts Offer Insights on Healthcare Companies: Zosano Pharma (ZSAN) and Vaxart (VXRT)
52 Vaxart, Inc. (NASDAQ:VXRT) Is a Buzzing Hot Stock
53 Form 8-K Vaxart, Inc. For: Nov 19
54 Genentech gets nod for big South San Francisco expansion plans
55 A Look At The Behavior Of Vaxart, Inc. (VXRT) Stock
56 3 Healthcare IPOs to Watch This Month
57 Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate
58 Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine
59 Vaxart, Inc. (NASDAQ:VXRT) Jumps 7.19%: A Look At The most Likely Path Going Forward
60 Chancery Won't Pause Vaxart Insider-Trading Suit In Del.
61 Why This Under-the-Radar Stock Is a Buy
62 Vaxart Announces Second Quarter 2020 Results Nasdaq:VXRT
63 Vaxart, Inc. (NASDAQ:VXRT) 94.92% Above its 52-week Low, How Long Will it Keep Rising?
64 Vaxart Announces IND Filed for COVID-19 Vaccine
65 Vaxart, Inc. (VXRT)’s -6.23% Retreat Makes It Worth Considering Again
66 Analysts Say You Should Buy Your Position in Vaxart, Inc. (NASDAQ:VXRT)
67 Vaxart Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility
68 Vaxart, Inc. Signs Memorandum of Understanding with Attwill Medical Solutions Sterilflow, LP
69 Why Vaxart Stock Is Vaulting Higher Today
70 Vaxart Announces Positive Hamster Challenge Study Data for its Oral COVID-19 Vaccine
71 Lost Money in Vaxart, Inc.?
72 Why Vaxart Stock Is Retreating Today
73 Vaxart's COVID-19 Vaccine Selected for the U.S. Government's Operation Warp Speed
74 What's the Outlook for Vaxart Stock?
75 Why Vaxart Stock Is Crushing It Today
76 If You Invested $5,000 in Vaxart in the March Market Crash, This Is How Much You'd Have Today
77 Why Vaxart Stock Is Under Pressure Today
78 Tiffany & Co. Q3 adjusted earnings Beat Estimates
79 Vaxart, Inc. Set to Join Russell 3000® Index
80 Everything You Need to Know About Vaxart and Its Potential Coronavirus Vaccine
81 Wall Street Analysts Are Bullish on Top Healthcare Picks
82 Vaxart Ramps Up Coronavirus Vaccine Production
83 Thinking about buying stock in Vaxart, Seanergy Maritime, AMC Entertainment, Delta Air Lines, or Norwegian Cruise Line?
84 Is Vaxart Stock a Buy?
85 Vaxart Announces First Quarter 2020 Financial Results and Provides Corporate Update
86 Vaxart, Inc. Investors: Company Investigated by the Portnoy Law Firm
87 Vaxart to Present at the Jefferies Virtual Healthcare Conference
88 Why Vaxart Stock Jumped Today
89 Covid-19 vaccine company under federal investigation after allegedly misrepresenting its role in government program Operation Warp Speed
90 Better Coronavirus Stock: Inovio vs. Vaxart
91 VAXART ANNOUNCES IT ENTERED INTO AN AGREEMENT WITH EMERGENT BIOSOLUTIONS FOR THE DEVELOPMENT AND MANUFACTURING OF ORAL CORONAVIRUS (COVID-19) VACCINE CANDIDATE
92 Is It Too Late to Buy Vaxart Stock?
93 Vaxart: No Midnight Bells Ringing Yet for This Cinderella Biotech Story
94 Vaxart's Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies
95 Could Investing in Vaxart Make You a Millionaire?
96 Vaxart, Inc. Appoints New CEO to Accelerate Advancement of COVID-19 and Other Programs
97 Scientists race to find 'warm' Covid vaccine to solve issue of cold storage
98 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Vaxart (VXRT) Investors to Securities Fraud Class Action, Encourages Investors with Losses to Contact its Attorneys Now
99 Vaxart Announces Additional Positive Pre-Clinical Data for its Oral COVID-19 Vaccine Program
100 Nov 20, 2020